Diabetes and risk of adverse events with calcium antagonists [3]

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 193-194

  Pahor, M ^a   Kritchevsky, S B ^a   Zuccala, G ^a   Guralnik, J M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; FOSINOPRIL; ISRADIPINE; NIFEDIPINE;

CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CORONARY RISK; DIABETES MELLITUS; DOSE RESPONSE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; MORTALITY;

EID: 0031975136     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.193     Document Type: Letter

References (11)